These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease. Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. Goedert M; Hasegawa M; Jakes R; Lawler S; Cuenda A; Cohen P FEBS Lett; 1997 Jun; 409(1):57-62. PubMed ID: 9199504 [TBL] [Abstract][Full Text] [Related]
8. Sites of phosphorylation in tau and factors affecting their regulation. Anderton BH; Betts J; Blackstock WP; Brion JP; Chapman S; Connell J; Dayanandan R; Gallo JM; Gibb G; Hanger DP; Hutton M; Kardalinou E; Leroy K; Lovestone S; Mack T; Reynolds CH; Van Slegtenhorst M Biochem Soc Symp; 2001; (67):73-80. PubMed ID: 11447841 [TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Sperber BR; Leight S; Goedert M; Lee VM Neurosci Lett; 1995 Sep; 197(2):149-53. PubMed ID: 8552282 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741 [TBL] [Abstract][Full Text] [Related]
11. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Hyman BT; Elvhage TE; Reiter J Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042 [TBL] [Abstract][Full Text] [Related]
12. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. Imahori K; Uchida T J Biochem; 1997 Feb; 121(2):179-88. PubMed ID: 9089387 [TBL] [Abstract][Full Text] [Related]
13. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Baum L; Hansen L; Masliah E; Saitoh T Mol Chem Neuropathol; 1996; 29(2-3):253-61. PubMed ID: 8971700 [TBL] [Abstract][Full Text] [Related]
15. Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Litersky JM; Johnson GV; Jakes R; Goedert M; Lee M; Seubert P Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):655-60. PubMed ID: 8687413 [TBL] [Abstract][Full Text] [Related]
16. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice. Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025 [TBL] [Abstract][Full Text] [Related]
17. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. Atzori C; Ghetti B; Piva R; Srinivasan AN; Zolo P; Delisle MB; Mirra SS; Migheli A J Neuropathol Exp Neurol; 2001 Dec; 60(12):1190-7. PubMed ID: 11764091 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases in intact cells. Buée-Scherrer V; Goedert M FEBS Lett; 2002 Mar; 515(1-3):151-4. PubMed ID: 11943212 [TBL] [Abstract][Full Text] [Related]
19. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Sheng JG; Jones RA; Zhou XQ; McGinness JM; Van Eldik LJ; Mrak RE; Griffin WS Neurochem Int; 2001; 39(5-6):341-8. PubMed ID: 11578769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]